King Pharmaceuticals KG Legacy Reinsurance — Total Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's legacy reinsurance — total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's legacy reinsurance — total assets?
- King Pharmaceuticals (KG) reported legacy reinsurance — total assets of $691.35M in Q1 2026.
- What does legacy reinsurance — total assets mean?
- The total value of economic resources controlled by the Legacy Reinsurance segment. This metric provides a baseline for assessing the scale and capital intensity of the segment's operations.